digital health companies glp-1 programs The Oprah Effect: The Shifting Conversation around Obesity and GLP-1s GLP-1 Business Report for Healthtech

We're treating these medications as standalone solutions rather than tools within a comprehensive metabolic health program

By David Prince, MD | Montefiore Medical Center Although new GLP-1 agonist weight loss drugs such as Ozempic, Wegovy, Trulicity, and Byetta are currently dominating the headlines, the majority of overweight Americans may not qualify for these medications due to limited availability and insurance plan restrictions

Always check the expiration date before using a pen

ByDrug 2024-02-05 10:07 4.764.632 -1 GLP-1RA --2 SGLT-2i 2...

Truven identified three major issues that payers are encountering with total population management as it relates to GLP-1 coverage.

Get 25% off your first treatment!